Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 2,494 | 2,864 | 3,813 | 2,612 | 2,326 |
| Operating Income | -2,494 | -2,864 | -3,813 | -2,612 | -2,326 |
| Other Income | -1 | 66 | -14 | 0 | 3 |
| Pre-tax Income | -2,496 | -2,798 | -3,827 | -2,612 | -2,323 |
| Net Income Continuous | -2,496 | -2,798 | -3,827 | -2,612 | -2,323 |
| Net Income | $-2,496 | $-2,798 | $-3,827 | $-2,612 | $-2,323 |
| EPS Basic Total Ops | -0.10 | -0.11 | -0.15 | -0.11 | -0.09 |
| EPS Basic Continuous Ops | -0.10 | -0.11 | -0.15 | -0.11 | -0.10 |
| EPS Diluted Total Ops | -0.10 | -0.11 | -0.15 | -0.11 | -0.09 |
| EPS Diluted Continuous Ops | -0.10 | -0.11 | -0.15 | -0.11 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.11 | -0.15 | -0.11 | N/A |
| EBITDA(a) | $-2,494 | $-2,864 | $-3,813 | $-2,612 | $-2,326 |